Skip to content

Non-Invasive Prenatal Cell-Free DNA Test for Chromosomal Abnormality Screening (NIPT)

Published: August 9, 2026Updated: August 16, 2026

This test checks for certain chromosomal abnormalities in your baby using a simple blood sample from you. It helps identify risks for conditions like Down syndrome, Edwards syndrome, or Patau syndrome.

Quick summary

["A simple blood test to screen for common chromosomal birth defects during pregnancy."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
75545-4
Short code
NIPT comment
Synonyms
NIPT comment
Category
chemistry
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Ref low
0.8
Ref high
1.2
Critical range
— – 5 N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
CPT
85610
SNOMED
396252006
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

How the Test Works

Your healthcare provider takes a small amount of blood from your arm. The blood is processed to extract tiny fragments of your baby’s DNA, which circulate in your bloodstream. Advanced laboratory techniques analyze these fragments to estimate the likelihood of chromosomal abnormalities.

What to Expect Before the Test

You may need to fast for a few hours before the blood draw, but this is not always required. Your provider will explain any specific instructions for your test. You’ll likely feel minimal discomfort during the draw, similar to a routine blood test.

What the Results Mean

Results are typically reported as a screening risk estimate rather than a definitive diagnosis. A low risk does not guarantee your baby is healthy, and a high risk means further testing (like amniocentesis) may be recommended. Always discuss results with your healthcare provider.

Who Should Consider This Test

NIPT is often recommended for women with certain risk factors (e.g., advanced maternal age, previous birth defects, or family history of chromosomal conditions). It can also be offered as a general screening option for all pregnant individuals.

Reference range

INR: 0.8-1.2 (warfarin: 2.0-3.0)N/A

Specimen: serum

Inform your healthcare provider if you are taking blood thinners. No special preparation required.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

◆Associated findings1

Short name

NIPT Screening

Frequently asked questions

Why is this test important?
NIPT provides an early, non-invasive way to screen for serious chromosomal abnormalities that could affect your baby’s health. Early detection allows for informed decisions about next steps, including additional testing or monitoring.
What are the limitations of this test?
NIPT is a screening test, not a diagnostic one. It may miss some abnormalities or give false results. It does not screen for genetic conditions or neural tube defects (like spina bifida). Always consult your provider for interpretation.
How often is this test performed?
NIPT is typically performed once during pregnancy, usually between 10 and 13 weeks. Results are ready within a few days to a week, depending on the lab.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy